Parkinsonism & Related Disorders

Papers
(The H4-Index of Parkinsonism & Related Disorders is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease114
Error-based biofeedback for gait training in Parkinson's disease78
Dual Phase 18F-FP-CIT PET in presynaptic and trans-synaptic nigrostriatal dysfunction in Multiple System Atrophy75
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.66
Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin65
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis62
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care60
Effect of ND0612 Continuous Infusion on Motor Performance and Experiences of Daily Living in Patients With Parkinson’s Disease57
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 202155
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 3454
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.51
FindPD.DaT: Development of a Novel Artificial Intelligence-driven Tool for Diagnosis of Parkinson’s Disease using Dopamine Transporter Scans51
Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson’s Disease using accelerometry45
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome37
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease36
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder36
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease35
Chorea-Acanthocytosis: A Case Report34
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment33
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention33
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.32
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease31
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease31
Evaluation of mild cognitive impairment in older patients with essential tremor30
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation30
The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials28
Psychometric analysis of the short form UCLA Loneliness Scale (ULS-8) in people with Parkinson's disease28
Asymmetric Parkinsonism and Ataxia with autonomic dysfunction and RBD28
0.065876960754395